Determining the optimal sequencing of bispecifics and CAR-T cells in patients with myeloma - YouTube
ASH 2022: Multiple Myeloma Highlights - The ASCO Post
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Therapy of relapsed-refractory multiple myeloma - Springer Healthcare IME
Première mondiale au CHU de Lille dans le traitement du cancer de la moelle osseuse - CHU Lille
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Pr Salomon MANIER - Auteur | Edimark
IACH on X: "Join us TODAY at 2pm Eastern Time (Atlanta), 8pm CET (Paris) for live news from #ASH21 with Dr. Salomon Manier and @Mohty_EBMT Register Free here: https://t.co/bdQmP2b0TS https://t.co/oYQD70BBZf" / X
Taper sur TOPORS rendrait l'AZA plus FORT… à l'aTAK ! ASH 2022 - E-journal | Edimark.fr
Salomon Manier
JNM2022 les traitements de la rechute - YouTube
Salomon MANIER, auteur sur Horizons Hémato
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Molecular prognostication in SMM | VJHemOnc
GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT | Bone Marrow Transplantation
Pr Salomon MANIER - Auteur | Edimark
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results | Nature Medicine
